CELG Quote, Trading Chart, Celgene Corporation

$ Last:

0.88% Change Percent:

$101.11 Open:

$101.86 Previous Close:

$102.02 High:

$101.11 Low:

2,053,419 Volume:

01/01/1970 12:00:00 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2019-10-17	101.11	101.86	102.02	101.11	2,053,419
2019-10-16	100.64	100.97	101.22	100.50	3,221,244
2019-10-15	100.50	100.95	101.185	100.40	2,655,352
2019-10-14	100.53	100.39	100.66	100.1111	1,836,076
2019-10-11	100.25	100.57	100.96	99.98	3,698,436
2019-10-10	99.73	99.81	99.90	99.26	3,238,951
2019-10-09	99.04	99.63	99.86	99.03	2,979,581
2019-10-08	99.25	98.88	100.02	98.67	4,213,530
2019-10-07	99.63	99.70	100.42	99.56	3,627,720
2019-10-04	98.51	99.87	100.10	98.43	3,469,435
2019-10-03	97.51	98.42	98.43	97.34	3,784,489
2019-10-02	98.97	97.62	98.98	97.30	4,375,627
2019-10-01	99.51	99.26	100.19	99.05	4,202,619
2019-09-30	98.85	99.30	99.93	98.53	5,198,727
2019-09-27	98.68	98.85	99.25	98.44	4,643,178
2019-09-26	98.58	98.59	98.88	97.97	3,763,368
2019-09-25	98.62	98.56	99.05	98.37	2,900,832
2019-09-24	99.80	98.62	99.85	98.48	4,523,337
2019-09-23	99.45	99.42	99.81	99.31	3,128,528
2019-09-20	98.65	99.37	99.66	98.50	5,387,529

Stock Information

Celgene Corporation Company Name:

CELG Stock Symbol:

NASDAQ Market:

Celgene Corporation Website:

CELG Quote, Trading Chart, Celgene Corporation

Get CELG Alerts

News, Short Squeeze, Breakout and More Instantly...

CELG - Amgen Blows Past EPS Estimates for the Second Quarter

What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
CELG - 3 Healthcare Stocks With a Solid Bottom Line -- and a Dividend

It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...
CELG - How These 15 Stock Suggestions Fared Against the Market

In this episode of Rule Breaker Investing , Motley Fool co-founder David Gardner and Motley Fool analysts Karl Thiel and Maria Gallagher review three Five-Stock Samplers. Learn about their businesses, why they went up or down, and what lessons you can take away from this review so that you ca...